# Administration of Dexmedetomidine Guided by Entropy/SPI Reduce

> **NCT02818621** · NA · UNKNOWN · sponsor: **Gangnam Severance Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Group Dex (dexmedetomidine)

## Key facts

- **NCT ID:** NCT02818621
- **Lead sponsor:** Gangnam Severance Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2016-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02818621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02818621, "Administration of Dexmedetomidine Guided by Entropy/SPI Reduce". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02818621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*